Triple

T21346166
Position Surface form Disambiguated ID Type / Status
Subject John A. Young E526342 entity
Predicate boardMemberOf P10 FINISHED
Object Affymetrix NE NERFINISHED

How this triple was built (3 steps)

Every LLM step that produced this triple, in pipeline order — named-entity classification, the disambiguation choices (the exact options shown, with the pick highlighted), and the generated description. The batch + timestamp of each is in the Provenance table below.

NER Named-entity recognition gpt-5-mini
Instruction
Given a phrase, classify it is english named entity (e.g., persons, organizations, works of art) in Latin script, or not (e.g., literals, dates, URLs, verbose phrases). For disambiguation, the statement where the phrase occurs as object is also given. Please return a JSON object with `phrase` (string, the phrase being analyzed) and `is_ne` (boolean, indicating whether the phrase is a Named Entity).
Input
Phrase: Affymetrix | Statement: [John A. Young, boardMemberOf, Affymetrix]
NED1 Entity disambiguation (via context triple) gpt-5-mini-2025-08-07
Target entity: Affymetrix
Context triple: [John A. Young, boardMemberOf, Affymetrix]
  • A. Illumina
    Illumina is a biotechnology company best known for developing and manufacturing advanced DNA sequencing and array-based technologies used in genomics research and clinical applications.
  • B. Array Technology Inc.
    Array Technology Inc. was the original name of ATI Technologies, a Canadian company best known for designing and manufacturing graphics processing units and chipsets later acquired by AMD.
  • C. Applied Biosystems
    Applied Biosystems is a biotechnology brand known for its instruments, reagents, and software used in DNA sequencing, PCR, and other molecular biology applications.
  • D. Cambridge Epigenetix
    Cambridge Epigenetix is a biotechnology company specializing in epigenetic sequencing technologies that enable more detailed and cost-effective analysis of DNA modifications for research and clinical applications.
  • E. Horizon Discovery
    Horizon Discovery is a biotechnology company specializing in gene editing and cell-based research tools used for drug discovery and development.
  • F. None of above. chosen
  • G. Unsure - the case is ambiguous/there is not enough information to decide.
NED2 Entity disambiguation (via description) gpt-5-mini-2025-08-07
Target entity: Affymetrix
Target entity description: Affymetrix was a biotechnology company best known for pioneering DNA microarray technology used in genomics and gene expression analysis.
  • A. Illumina
    Illumina is a biotechnology company best known for developing and manufacturing advanced DNA sequencing and array-based technologies used in genomics research and clinical applications.
  • B. Array Technology Inc.
    Array Technology Inc. was the original name of ATI Technologies, a Canadian company best known for designing and manufacturing graphics processing units and chipsets later acquired by AMD.
  • C. Applied Biosystems
    Applied Biosystems is a biotechnology brand known for its instruments, reagents, and software used in DNA sequencing, PCR, and other molecular biology applications.
  • D. Cambridge Epigenetix
    Cambridge Epigenetix is a biotechnology company specializing in epigenetic sequencing technologies that enable more detailed and cost-effective analysis of DNA modifications for research and clinical applications.
  • E. Horizon Discovery
    Horizon Discovery is a biotechnology company specializing in gene editing and cell-based research tools used for drug discovery and development.
  • F. None of above. chosen

Provenance (2 batches)

The batch behind each pipeline step, in order, with when it ran. Timestamps are batch-level — stages were processed in waves, so the object chain (NER → NED1 → NEDg → NED2) reads in order, but predicate / elicitation batches can sit in a different wave.

Step Stage Batch ID Status When
creating Elicitation batch_69e0b51cd5cc81909ac1187971e8a8ad completed April 16, 2026, 10:08 a.m.
NER Named-entity recognition batch_69ee5ba7ce3c8190ba5ded980a9866f2 completed April 26, 2026, 6:38 p.m.
Created at: April 16, 2026, 4:55 p.m.